ProjectIVAC-ALL-1
Basic data
Title:
IVAC-ALL-1
Duration:
01/10/2016 to 31/12/2018
Abstract / short description:
Prospective phase I/II study: Patient-individualized peptide vaccination based on whole exome sequencing with adjuvant GM-CSF in children with relapsed acute lymphoblastic leukemia
Involved staff
Managers
Faculty of Medicine
University of Tübingen
University of Tübingen
Contact persons
Faculty of Medicine
University of Tübingen
University of Tübingen
Local organizational units
University Children’s Hospital - Department of Paediatrics
Hospitals and clinical institutes
Faculty of Medicine
Faculty of Medicine
Funders
Heidelberg, Baden-Württemberg, Germany